Partner therapy announces publication of clinical trial results show significant benefit of using Leukine® (sargramostim) in patients with Alzheimer’s disease
LEXINGTON, Mass., March 24, 2021 / PRNewswire / – Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, announces publication of results from an investigator-initiated clinica…
